Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disease Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00204490
What this trial is testing

Soy Isoflavones and Breast Cancer Risk Reduction

Who this might be right for
Breast Cancer
The University of Texas Medical Branch, Galveston 197
Testing effectiveness (Phase 2)Study completedNCT02197897
What this trial is testing

Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors

Who this might be right for
Bladder Cancer
Baylor College of Medicine 15
Not applicableStudy completedNCT02829060
What this trial is testing

Endourology Disease Group Excellence (EDGE) Consortium: Antibiotics (Abx) for Percutaneous Nephrolithotomy (PCNL) Part 2

Who this might be right for
NephrolithiasisUrinary Tract Infection (UTI)Sepsis
University of California, San Diego 330
Not applicableLooking for participantsNCT06626360
What this trial is testing

Screening for Malnutrition in Obese Patients

Who this might be right for
Overweight and Obese AdultsMalnutrition or Risk of Malnutrition
HAN University of Applied Sciences 2,000
Not applicableStudy completedNCT03324438
What this trial is testing

Home Telemedicine to Optimize Health Outcomes in High-Risk Youth With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University of Colorado, Denver 108
Not applicableNot Yet RecruitingNCT07341958
What this trial is testing

INtensive liPid-lowering Therapy for Acute High-risk IntracRanial or Extracranial atheroSclerosis -II (INSPIRES-2)

Who this might be right for
Ischemic Stroke or High-risk TIA (ABCD² ≥ 4)
Beijing Tiantan Hospital 242
Not applicableStudy completedNCT04320043
What this trial is testing

Adjacent Segment Disease After Anterior Cervical Decompression Surgery

Who this might be right for
Adjacent Segment DiseaseCervical MyelopathyCervical Radiculopathy+1 more
Zuyderland Medisch Centrum 673
Early research (Phase 1)Looking for participantsNCT07501117
What this trial is testing

Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma

Who this might be right for
Uveal Melanoma
Inge Marie Svane 15
Not applicableWithdrawnNCT00796874
What this trial is testing

Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute
Not applicableUnknownNCT06151613
What this trial is testing

Continuous Non-invasive Electrophysiological Monitoring in High Risk Pregnancies

Who this might be right for
Perinatal OutcomesPreterm BirthHigh Risk Pregnancy
Maxima Medical Center 1,911
Testing effectiveness (Phase 2)Study completedNCT01176552
What this trial is testing

Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer

Who this might be right for
Renal Cell Carcinoma
Kidney Cancer Research Bureau 35
Post-approval studies (Phase 4)Looking for participantsNCT07025148
What this trial is testing

Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)

Who this might be right for
Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)
University of Florida 40
Not applicableStudy completedNCT03278678
What this trial is testing

Nutritional Screening in Older Individuals

Who this might be right for
Malnourished
Sanjuan, Silvia Forcano, M.D. 791
Testing effectiveness (Phase 2)Study completedNCT05084235
What this trial is testing

The Cardiac Effects of Empagliflozin in Patients With High Risk of Heart Failure

Who this might be right for
Heart FailureObesity
Jacob Moller 191
Not applicableStudy completedNCT04922840
What this trial is testing

Improved Cardiovascular Health for Patients With Inflammatory Joint Diseases

Who this might be right for
SpondyloarthritisRheumatoid ArthritisPsoriatic Arthritis
Diakonhjemmet Hospital 60
Early research (Phase 1)Looking for participantsNCT07249840
What this trial is testing

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

Who this might be right for
JAK2 Mutation
Brigham and Women's Hospital 12
Not applicableLooking for participantsNCT07587268
What this trial is testing

Molecular Profiling for Risk Stratification in Appendiceal Cancer

Who this might be right for
Appendiceal CancerAppendiceal Adenocarcinoma
City of Hope Medical Center 400
Testing effectiveness (Phase 2)Study completedNCT00475150
What this trial is testing

Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+8 more
National Cancer Institute (NCI) 39
Not applicableLooking for participantsNCT07452991
What this trial is testing

ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE

Who this might be right for
Pulmonary Embolism (PE)
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 300
Not applicableStudy completedNCT04540718
What this trial is testing

Exercise and Sauna on Blood Pressure and Cardiovascular Health

Who this might be right for
Cardiovascular Risk FactorHeat StressSedentary Behavior
University of Jyvaskyla 47
Next Page